FOXH1

(redirected from fast-2)

FOXH1

A gene on chromosome 8q24.3 that encodes a member of the forkhead family of transcription factors, which activates an activin response element.
References in periodicals archive ?
Efficacy data for FAST-2 meets primary endpoint, FAST-1 and FAST-2 combined analysis demonstrates a reduction in time to onset of symptom relief
6 hours with placebo) and 2 hours in FAST-2 (versus 12 hours with comparator)
Nasdaq:KOSP) announced today preliminary results from two pivotal Jerini AG (FSE: JI4) Phase III Icatibant clinical trials, FAST-1 and FAST-2 (For Angioedema Subcutaneous Treatment), for the subcutaneous treatment of hereditary angioedema (HAE), a debilitating and potentially life-threatening genetic disease.
The FAST-2 trial treated a total of 74 patients at clinical sites in 10 European countries and in Israel in a double-blind study against the comparator, tranexamic acid.
The primary endpoint of FAST-2, as measured by a VAS, was met with a median time to onset of symptom relief of 2 hours for Icatibant versus 12 hours for tranexamic acid (p less than 0.
A total of 11 laryngeal attacks were treated in the FAST-1 and FAST-2 trial controlled phase, with patients reporting a median time of 1 hour (FAST-2) and 0.